Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol Myers Squibb Tops Q4 Estimates
Bristol Myers Squibb Tops Q4 Estimates
Bristol Myers Squibb Tops Q4 Estimates
Submitted by
admin
on February 6, 2025 - 11:52am
Source:
Motley Fool
News Tags:
Bristol Myers Squibb
earnings
Headline:
Bristol Myers Squibb Tops Q4 Estimates
snippet:
Adjusted EPS of $1.67 beat expectations of $1.46.
Revenue rose to $12.3 billion, exceeding estimates of $11.57 billion.
The growth portfolio of drugs saw a 21% revenue increase, driven by Reblozyl, Breyanzi, and Camzyos.
Do Not Allow Advertisers to Use My Personal information
